Compare FITB & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FITB | A |
|---|---|---|
| Founded | 1858 | 1999 |
| Country | United States | United States |
| Employees | 18676 | N/A |
| Industry | Major Banks | Biotechnology: Laboratory Analytical Instruments |
| Sector | Finance | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 45.2B | 39.8B |
| IPO Year | N/A | 1999 |
| Metric | FITB | A |
|---|---|---|
| Price | $49.89 | $135.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 16 | 15 |
| Target Price | $55.13 | ★ $161.47 |
| AVG Volume (30 Days) | ★ 5.0M | 2.2M |
| Earning Date | 04-17-2026 | 05-27-2026 |
| Dividend Yield | ★ 3.21% | 0.92% |
| EPS Growth | N/A | ★ 3.16 |
| EPS | N/A | ★ 1.07 |
| Revenue | N/A | ★ $4,472,000,000.00 |
| Revenue This Year | $57.09 | $8.45 |
| Revenue Next Year | $7.06 | $6.13 |
| P/E Ratio | ★ $15.20 | $127.07 |
| Revenue Growth | N/A | ★ 6.43 |
| 52 Week Low | $37.29 | $108.35 |
| 52 Week High | $55.44 | $160.27 |
| Indicator | FITB | A |
|---|---|---|
| Relative Strength Index (RSI) | 55.68 | 76.61 |
| Support Level | $49.08 | $121.63 |
| Resistance Level | $50.86 | $137.85 |
| Average True Range (ATR) | 0.90 | 3.63 |
| MACD | 0.14 | 2.39 |
| Stochastic Oscillator | 83.02 | 87.55 |
Fifth Third Bancorp is a midsize regional bank in the US, with total assets of around $300 billion as of March 2026. The bank closed its acquisition of Comercia in February 2026. Headquartered in Cincinnati, Ohio, Fifth Third has a strong presence in the US Midwest and is currently expanding in the US Southeast. The bank provides a diversified set of financial services in retail banking, commercial banking, card and Treasury management, wealth and asset management, and capital markets.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.